Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Nanoalvand

Clinical trials sponsored by Nanoalvand, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Brain tumor drug safety under scrutiny: temozolomide liver risk study launched Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Brain tumor drug safety under scrutiny: temozolomide liver risk study launched

Disease control Recruiting now

This study looks at how safe and effective temozolomide (brand name Amitzo) is for people with aggressive brain tumors (grade III and IV gliomas). Researchers are tracking 100 patients to see how often liver injury occurs and to monitor other side effects. The goal is to better u…

Sponsor: NanoAlvand • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC